ID

15354

Description

Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01) https://clinicaltrials.gov/ct2/show/NCT02419378 Principal Investigator Prof. Dr. Dr. Sven Meuth, University Hospital Muenster, Germany

Lien

https://clinicaltrials.gov/ct2/show/NCT02419378

Mots-clés

  1. 13/08/2015 13/08/2015 - Martin Dugas
  2. 23/05/2016 23/05/2016 -
  3. 28/05/2016 28/05/2016 -
Téléchargé le

28 mai 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Discontinue Trial Medication Multiple Sclerosis ALAIN01 NCT02419378

Discontinue Trial Medication Multiple Sclerosis ALAIN01 NCT02419378

Discontinue Trial Medication
Description

Discontinue Trial Medication

Alias
UMLS CUI-1
C0013227
UMLS CUI-2
C0457454
Patient ID (derived)
Description

Patient ID (derived)

Type de données

text

Alias
UMLS CUI [1]
C2348585
Discont. of Trial Medication: Date
Description

Discont. of Trial Medication: Date

Type de données

date

Alias
UMLS CUI [1,1]
C1521826
UMLS CUI [1,2]
C0806020
If other reason was selected, please specify
Description

Other reason

Type de données

text

Alias
UMLS CUI [1]
C3840932
Reason for discontinuation
Description

Reason for discontinuation

Type de données

integer

Alias
UMLS CUI [1,1]
C0566251
UMLS CUI [1,2]
C0457454
Discont. of Trial Medication: Reason Text
Description

Discont. of Trial Medication: Reason Text

Type de données

text

Alias
UMLS CUI [1,1]
C0457454
UMLS CUI [1,2]
C0566251
Discont. of Trial Medication: Date of Signature
Description

Date of Signature

Type de données

date

Alias
UMLS CUI [1,1]
C1519316
UMLS CUI [1,2]
C0011008

Similar models

Discontinue Trial Medication Multiple Sclerosis ALAIN01 NCT02419378

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Discontinue Trial Medication
C0013227 (UMLS CUI-1)
C0457454 (UMLS CUI-2)
Patient ID (derived)
Item
Patient ID (derived)
text
C2348585 (UMLS CUI [1])
Trial medication end date
Item
Discont. of Trial Medication: Date
date
C1521826 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Other reason
Item
If other reason was selected, please specify
text
C3840932 (UMLS CUI [1])
Item
Reason for discontinuation
integer
C0566251 (UMLS CUI [1,1])
C0457454 (UMLS CUI [1,2])
Code List
Reason for discontinuation
CL Item
Investigator considers it would be in the best interests of the patient (1)
CL Item
Unacceptable toxicity of the study drug (2)
CL Item
HIV infection (3)
CL Item
Patient requests discontinuation (4)
CL Item
Patient is unable or unwilling to comply with planned study safety monitoring (5)
CL Item
Other reason: ____________ (6)
Discontinuation reason
Item
Discont. of Trial Medication: Reason Text
text
C0457454 (UMLS CUI [1,1])
C0566251 (UMLS CUI [1,2])
Date of Signature
Item
Discont. of Trial Medication: Date of Signature
date
C1519316 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial